• DNA Capital's funds increased their stake in CM Hospitalar to approximately 47.03%, excluding treasury shares, according to a November 6, 2026 notice.
• The funds now hold 601,708,118 common shares following a capital increase ratified on October 30, 2026.
• Subscriptions covered shares available through preemptive rights and unsubscribed shares.
• Payment combined cash with capitalization of receivables from the company's nonconvertible debentures held by DNA Capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CM Hospitalar SA published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.